Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated PatientsStephen J. Nicholls, Steven E. Nissen, Leslie Cho et al.|JAMA|2016Cited by 1.1k
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trialFrederick J. Raal, Daniel Gaudet, Evan A. Stein et al.|The Lancet|2014Cited by 750